In July 2018, a class-action lawsuit
was filed against CVS for allegedly marketing the supplement Algal-900 DHA as being clinically shown to improve memory and cognitive function and claiming the product is capable of reducing errors by “50% or more” in an “episodic memory test” when, according to the plaintiffs, the product does not work as advertised and CVS does not have adequate scientific support to make such claims. (Ferguson et al v. CVS Pharmacy, Inc.
, Case NO. 18-cv-1529, S.D. Cal.)
To read about TINA.org’s legal actions pertaining to this CVS supplement, click here and here.
For more of TINA.org’s coverage of CVS, click here.